Pilot Surgical PK Study of BGB324 in Recurrent | Clinical Research Studies Listing

Build status - In Progress

Recruiting

18 years - 99 years

All

Phase 1

5 participants needed

1 Location

Brief description of study

The purpose of this study is to test the ability of a new drug, BGB324, to get into the brain tumor (e.g.by crossing the blood brain barrier) in patients with recurrent glioblastoma who require surgery.

Detailed description of study

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Medical Research
Age: 18 years - 99 years
Gender: All

History of confirmed Glioblastoma (GBM) Treatment for no more than 2 prior relapses Patients must be 18 years of age or older

Updated on 04 Aug 2024. Study ID: 832050

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.